Valued at a market cap of $126.4 billion, Medtronic plc (MDT) develops, manufactures, and sells device-based medical ...

Medtronic will invest $90M in Anteris Technologies for DurAVR TAVR device development, contingent on a $200M IPO.

We recently published 10 Stocks Jim Cramer Talked About. Medtronic plc (NYSE:MDT) is one of the stocks on Jim Cramer talked ...

Okay. Hello, everyone. Thanks for joining us today. I'm Ryan Weispfenning, Vice President and Head of Investor Relations at Medtronic. Thank you for joining call showcasing the Altaviva device, which ...

In the latest trading session, Medtronic (MDT) closed at $101.34, marking a +1.05% move from the previous day. The stock exceeded the S&P 500, which registered a gain of 0.55% for the day. Meanwhile, ...

Medtronic plans to invest up to $90 million in Anteris Technologies Global Corp., a company that’s dual headquartered in ...

Medtronic, IQVIA and GE HealthCare show how medical device leaders are turning analytics, AI and enterprise data platforms ...

Medtronic is an undervalued AI stock with an elite dividend program. Artificial intelligence (AI) is ushering in a new era of innovation that promises to upend industries across the spectrum, and the ...

We recently published a list of 15 Stocks on Jim Cramer’s Radar. In this article, we are going to take a look at where Medtronic plc (NYSE:MDT) stands against other stocks on Jim Cramer’s radar. On ...

Medtronic is a healthcare behemoth, developing and manufacturing medical devices for chronic diseases, with a broad and dominant portfolio of industry-leading products. The company has increased its ...

Medtronic plc MDT recently received Food and Drug Administration (“FDA”) approval for the minimally invasive implantable tibial neuromodulation (ITNM) Altaviva device. The therapy is inserted near the ...